Tag Archives: drug prices

Capitol Hill Healthcare Update

By Chris Jones on April 29, 2019 Posted in Congress, Healthcare

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. DRUG PRICES: CONGRESS RETURNS, PICKS UP WHERE LAWMAKERS LEFT OFF Congress reconvenes today after a two-week spring recess, with lawmakers in both parties continuing their focus on prescription drug prices. House and Senate committees are planning a … Continue Reading

Capitol Hill Healthcare Update

By Chris Jones on April 8, 2019 Posted in Congress, Federal Policy, Healthcare

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. HOUSE PANEL TO VOTE ON BIPARTISAN DRUG PRICING MEASURE The House Ways and Means Committee is scheduled to vote Tuesday on legislation that contains several prescription drug pricing provisions, including requiring pharmacy benefit managers to disclose details … Continue Reading

Capitol Hill Healthcare Update

By Chris Jones on March 11, 2019 Posted in Healthcare

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Azar testifies before three committees on HHS’ budget; a series of Senate bills targeting pharma introduced; medical device tax repeal legislation introduced – but only in the Senate; outpatient physicians plan to lobby on … Continue Reading

The Weekly Hill Update

By Adam Higgins on March 4, 2019 Posted in The Weekly Hill Update

Below is the Federal Policy team’s weekly preview, published each week when Congress is in session. HEADLINES • The House will take up H.R. 1, a broad measure addressing voting rights, campaign finance and government ethics laws. • Michael Cohen, the former attorney for President Donald Trump, continues his behind-closed-doors testimony at the House Intelligence … Continue Reading

Finger-pointing but few fireworks at Senate hearing on drug prices

By Chris Jones and Adam Higgins on February 26, 2019 Posted in Healthcare

Amid finger-pointing but few real fireworks, the seven pharmaceutical executives testifying before the Senate Finance Committee today offered lawmakers a spirited defense of the industry but also substantive policy concessions to address drug prices. They avoided gaffes and left the industry in no worse a political position than before the hearing. Democrats predictably were unsatisfied, … Continue Reading

Capitol Hill Healthcare Update

By Chris Jones on February 4, 2019 Posted in Healthcare

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Trump will discuss healthcare and drug costs in this week’s State of the Union address; Democrats criticize HHS’ drug rebate proposal; dueling hearings highlight the ACA’s pre-existing conditions; House Democrat reveals her cancer is … Continue Reading

Capitol Hill Healthcare Update

By Chris Jones on January 22, 2019 Posted in Federal Policy, Healthcare

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. We’re posting on Tuesday this week because of the Martin Luther King, Jr. federal holiday. Highlights this week: Gottlieb warns FDA’s funds running low as shutdown continues; House Dems launch sweeping probe on drug prices, Senate approves … Continue Reading